A relational schema is described for capturing highly parallel gene expression experiments using different technologies. This schema grew out of efforts to build a database for collaborators working on different biological systems and using different types of platforms in their gene expression experiments as well as different types of image quantification software. The tables are conceptually organized into three categories of information: Platform, Experiment (which includes image scanning and quantification), and Data. The strengths of the schema are: (i) integrating information on array elements using a gene index; (ii) describing samples using ontologies; (iii) reducing an experiment to a single RNA source for precise descriptions yet not losing the relationships between experiments done at the same time or for the same project; and (iv) maintaining both raw and processed (e.g. cleansed and normalized) data and recording how the data is processed. The result is a novel schema, which can hold both array and non-array data, is extensible for detailed experimental descriptions that are precise and consistent, and allows for meaningful comparisons of genes between experiments. Availability: The schema is available at
INTRODUCTION
The advent of highly parallel methods for quantitative assessment of gene expression levels has led to new opportunities and challenges. The opportunity exists to simultaneously survey every gene expressed in a cell, yet the challenge remains to know what those genes are. The opportunity exists to classify genes and cells based * To whom correspondence should be addressed. 2 Present address: Department of Molecular Cell Biology, Weizmann Institute of Science, Israel. on expression profiles, yet the challenge remains as to how to compare the results from different experiments. Comparisons are made difficult when different types of technologies are used and different representations of the same gene must be resolved. Moreover, difficulties arise when merging of different representations of the same cell or tissue is necessary. To enable these comparisons and the interpretation of gene expression data on the scale of thousands to billions of data points, databases with sufficient representational power to hold this information are necessary.
Gene expression databases have been built for individual efforts and by companies to support their products. In general, these efforts focus on a single technology (usually array based) with rich descriptions of how the array is built but little structured information on the biological state of the samples. ArrayDB (Ermolaeva et al., 1998) is an example that focuses on 2-color fluorescent arrays. The GATC schema (http://www.gatconsortium.org/specifications.html) includes lithographically-produced oligo chips but does not cover SAGE and is limited in sample descriptions. Efforts to meet these requirements have begun in the form of public repositories (Brazma et al., 2000) . We have built a relational database, RNA Abundance Database (RAD) to hold gene expression data from collaborators working on different biological systems and using different types of platforms in their experiments (including array and non-array methods) as well as different types of image quantification software. A cross-experiment, cross-platform comparison necessitates the use of common controls for normalization. The RAD schema has been developed to incorporate different approaches to normalization, as well as data cleansing. The schema also provides for integration of sample descriptions and gene descriptions using ontologies and a gene index respectively, and it provides space for annotation of the experimental parameters themselves. Although it can be viewed as a stand-alone database, RAD is part of a larger framework for gene annotation. It is through this framework, the Genomics Unified Schema (GUS, Davidson et al., 2001) , that RAD obtains gene annotations and shared controlled vocabularies (e.g. taxonomy). A gene expression database, ExpressDB, has recently been described with similar goals and capabilities (Aach et al., 2000) . RAD differs from ExpressDB in the approaches taken to represent sample information and comparisons of data from different studies, and in its overall schema design. ExpressDB was primarily designed to hold yeast data although extensions to other species are planned. RAD, on the other hand, currently holds mammalian data and can easily capture data from other species as well. We present a detailed description of the RAD schema and its use, which elucidates important concepts to be considered in the design of gene expression databases.
SYSTEMS AND METHODS
The RAD schema is conceptually organized into sets of tables to provide a logical representation of a gene expression experiment as a whole. The three main sets are: Platform, Experiment, and Data. The Platform tables hold information on the particular platform used and the genes investigated, such as platform type, location information, and external identifiers. (While expression levels of genes are what is being sought, it is actually gene representations or 'tags' that are used to measure RNA abundance levels. These gene tags may be PCR products, oligos, or-in the case of SAGE-sequence tags.)
The Experiment tables hold details on how each experiment was performed, associated experimental parameters, precise descriptions of the RNA source, and scanning and image quantification software utilized. The Data tables hold the quantitative information for the expression experiment: raw values, parsed directly from image analysis programs, as well as processed or derived values. In general, one platform can be used in many experiments, one experiment provides many data rows, and the data can be processed in many ways. For several tables in the Experiment and Data categories, views have been created to allow for simultaneous storage of information from different platforms and quantification programs. These views are not the same as materialized views that provide precalculated values to improve database query performance. Instead, the views rename attributes of a low-level generic table for specific implementations.
Additionally, RAD contains a set of meta-data tables, which act as an electronic lab notebook, keeping track of table relationships, users, and associated information on their activity inserting and manipulating data, such as clean-up and normalization efforts. Moreover, the user information tables are utilized to set read/write permissions for each row in a table, allowing storage of both public and proprietary data.
A list of tables organized by these logical sets is given in Table 1 . Also listed are the GUS shared resources used in RAD to provide precise descriptions of the experimental samples. The complete schema can be viewed on-line at http://www.cbil.upenn.edu/ cgi-bin/RAD2/schemaBrowserRAD.pl. Slides illustrating the overall schema diagram and how views are built over common low-level data tables are available at (http://www.cbil.upenn.edu/RAD2/schema.html).
A gene expression experiment consists of several parts (Figure 1 ). RNA is extracted from a sample. The RNA (usually in the form of cDNA) is labeled. Controls can be added prior to labeling or labeled separately. The labeled material is hybridized to an array and excess material washed off. The array is scanned and the image is quantified. For SAGE, sequencing the concatenated ditags is analogous to hybridizing the labeled material to an array (Velculescu et al., 1995) . Software that translates the SAGE sequence files into counts for the different sequence tags is analogous to image analysis software for quantifying spots on arrays. Ideally, sufficient information should be captured about each step to allow the experiment to be reproduced, as one would provide in a publication. The microarray community is developing such minimal requirements for gene expression experiments, which cover these steps in detail (MGED group).
Platform tables
Information on the genes represented in a given platform is captured in the SpotImp and SpotFamilyImp tables. 'Spot' represents individual instances of a gene tag whereas 'SpotFamily' represents all instances of a gene tag. For example, the PCR product from an individual clone may be spotted in duplicate on a filter array or on a two-channel microarray. In the case of Affymetrix chips, the identity of an individual oligo is not currently available. Indeed, published reports (Tamayo et al., 1999) have simply listed a single processed value summarizing the signals from the matched and mismatched probe sets. For these cases, a one to one correspondence will exist between 'Spot' and 'SpotFamily' for those genes represented by one probe set. It should be noted that if the individual Affymetrix probe sets (matched and mismatched) are available, these could be considered spots and the common RNA sequence they are interrogating considered the spot family. SAGE sequence tags are handled differently as discussed below.
The 'Imp' suffix indicates that table views are used to provide platform and quantification software specific attributes, allowing us to store similar types of information without naming constraints. Thus specific information on many different platforms/quantification 
SAGE.) The raw count information for a particular tag cannot be subdivided across UniGene cluster assignments when more than one is applicable. Thus the data is stored as the equivalent of summary values, in SpotFamilyResult, and no quantification is recorded for the 'individual' cluster assignments in SpotResult.
An advantage of using views to represent all of the platforms (and quantification software) within the same set of tables is that queries across the same external identifier can be done efficiently to identify all instances. This type of query would be used for cross-platform comparison of experiments. Since the physical manifestation of the gene varies from platform to platform (e.g. PCR product, oligo, sequence tag), views provide a platform-specific label for attributes of the gene, and subsequent analysis steps. This simplifies development of tools to insert and retrieve data by allowing for general scripts that use view-specific subroutines or packages when necessary. As an example, the data from Alizadeh et al. (2000) was obtained from experiments utilizing a custom two-channel microarray platform (the 'lymphochip') and quantified through the ScanAlyze software (http://rana.lbl.gov). ScanAlyze views were created for Platform tables (ScanAlyzeSpot, ScanAlyzeSpotFamily) as well as for Experiment (ScanAnlyzeImage, ScanAlyzeAnalysis) and Data tables (ScanAlyzeSpotResult). Table 2 illustrates how the attributes in the SpotFamilyImp table are used in the ScanAlyzeSpotFamily view along with a sample row.
Interpreting gene expression data requires knowing much more than the identity of a gene. An external identifier provides a starting point to acquire information about a gene but if the pointer is simply to a GenBank accession or IMAGE clone ID then the process will be very inefficient and time-consuming especially when many genes are involved. Our approach is to use a gene index, which integrates all publicly available ESTs for human and mouse. This index, originally built as the Database of Transcribed Sequences (DoTS) but now incorporated into GUS (http://www.allgenes.org), clusters and assembles EST (and mRNA) sequences to generate consensus Transcribed Sequences (TSs). These TSs are comparable to the concept of Functionally Distinguishable RNA (FDR) fragments described by Aach et al. (2000) . Each TS is then compared to sequences for known genes and searched for protein motifs in order to assign function. A cell role is also assigned if sufficient information exists on characterized genes.
Not only can this annotation be used to interpret gene expression data but it can also be used to formulate queries based on the assembly of ESTs and the associated annotation. For example, queries regarding the human betaglobin gene would retrieve expression data for three IM-AGE clones if done using the GUS index. The expression data can also be filtered to focus attention on a particular type of genes such as 'transcription factors' or on genes that are located on a specified chromosome (from radiation hybrid mapping of a constituent EST).
Experiment tables
The Experiment table in our schema represents the analysis of an individual hybridization to one array or a single SAGE analysis. Information on (or pointers to) the platform used, experimental conditions and who did the experiment is kept in this table. Description of sample(s) is done independently of these and is related through ExperimentSample (more details on this are given later). An ExperimentControlGenes table describes the type of control (e.g. spiked genes or housekeeping genes) and provides pointers to ControlGenes. Details of the protocols used (e.g. hybridization and washing) are stored in separate tables. These subdivisions allow us to apply a consistent description to a group of experiments, while also eliminating duplicate information in the database. Once a protocol has been created and assigned to an experiment, it can then be associated with another of the same group.
Scanner information and image analysis software details are stored in an ExperimentImageImp and an ExperimentResultImp table respectively. The 'Imp' suffix refers to the fact that views are used on these tables to provide case-specific names to attributes, as was described for the Platform tables. Views are used in this manner for Data tables as well. For example, microarray experiments using the ScanAlyze program will have parameters specific to that program such as image used and SAG file. Obviously, SAGE experiments will have unique attributes such as sequence file but these are simply mapped to pic filename in the ExperimentImageImp table. Experiment is the parent of ExperimentImageImp, which in turn is the parent of ExperimentResultImp. This is because a single hybridization experiment can be scanned and quantified using different exposures/settings.
Note that, in fluorescent microarray experiments, samples labeled with different dye tags are routinely mixed. These are considered as two experiments in our schema, which are related in a separate table, RelatedExperiment. This distinction is made in order to allow a more precise description of each sample source. Another advantage is that details of each signal can be handled independently. By comparison, ExpressDB (Aach et al., 2000) does not represent related experiments through a structured RelatedExperiment concept, but simply accepts the way related data are packaged together by the data providers. RelatedExperiment also contains identifiers for the combined experiment and information such as which is the red or the green channel. The latter functionality is strictly for convenience in querying, with more precise descriptions of labeling reserved for the Label table.
Just as it is important to relate experiments performed simultaneously, it is important to relate experiments done as part of the same project such as in a time study, drug trial, or examination of related types of cells, as well as to relate replicate experiments. The Groups and ExperimentGroups tables are used to relate these experiments and contain quantitative information (value, units) about the order of the experiments when appropriate. For example, if a series of hybridization experiments were performed to survey expression levels at different time points when serum starvation was used to induce differentiation in fibroblasts (as in Iyer et al., 1999) , the group type in Groups might be 'time series' and the value and units for each experiment of this group in ExperimentGroups indicate the time of serum removal for the sample used in that experiment (e.g. 24 h). Another use of the ExperimentGroups table is that collections of experiments across which comparisons are meaningful can be formed and stored.
Each experiment has at least one sample, however, the same sample may be used in many experiments. It is also conceivable that pooled material may be labeled together. We have allowed the notion of a set of sample materials in the schema that permits description of multiple treatments, diseases, and tissue sources for a particular experiment. It is assumed that only a single treatment has been performed on an individual sample, that an individual sample has only a single disease and only one anatomy (tissue/cell). Multiple treatments, diseases, and anatomy types are handled as different samples in the same experiment sample set. A table relating Sample and Experiment allows for different combinations of existing Sample entries to create a suitable set for any given experiment.
Precisely describing the RNA source is both important and difficult. It is important to know exactly what the RNA sample represents in terms of cell, tissue, organism, developmental stage, and relevant history in order to interpret the resulting data particularly when comparisons are desired with other experiments. It is difficult to describe these categories of information with sufficient structure to allow meaningful queries across them. We have incorporated ontologies where available to not only provide controlled vocabularies for these categories but also to provide a hierarchical structure of terms allowing queries to include superstructure and substructure terms. As indicated in Table 1 , the relevant tables are a shared resource that is used for our gene index, GUS. The Taxon  table uses (Blake et al., 2000) to include human terms and expand description of systems such as hematopoiesis using medical textbooks as sources (Stedman, 1982; Williams et al., 1989) . The Anatomy hierarchy includes 'cell lines' as a substructure for many different types of cells to distinguish immortalized from primary cells (see Table 3 and http://www.cbil.upenn.edu/anatomy.php3). The Disease table uses the KEGG (Kanehisa and Goto, 2000) representation of the CDC ICD-9 classification (http://www.cdc.gov/nchs/icd9.htm). The KEGG representation has associated MIM identifiers (OMIM, 2000) with many of the ICD-9 terms (Center for Disease Control). Our approach, therefore, has been to incorporate standard ontologies wherever possible to avoid semantic difficulties when communicating with other databases.
Data tables
The raw data obtained from the gene expression experiment are stored in the SpotResultImp table. Views are created for each image analysis program to name the output parameters appropriately. As can be discerned from the table name, SpotResult primarily refers to quantitative data on array elements obtained from scanning a hybridized array. For reasons involving the many to many relationship between SAGE sequence tags and gene assignments (discussed earlier), the SpotResult table is not used for SAGE data. Each array element has a SpotResult row. However, multiple array elements may represent the same gene tag and a summary value is desired to describe the expression level of that gene tag. For example, commercial filter arrays (GenomeSystems, Clontech) contain duplicate spots. We use a SpotFamilyResult table to relate array elements that should be combined and provide a summary value such as an average value for all elements.
The raw and summarized values can in turn be processed in a variety of ways prior to being analyzed to investigate a particular question. For example, summarized intensities on a filter array can be normalized to total intensity of all signals, one fluorescent channel in a two-channel mi- Table 3 . Anatomy hierarchy. Sample showing the bone marrow cells hierarchy. The sources of terms and their location in the hierarchy are the Gene Expression Database from the Jackson Labs (GXD, Ringwald et al., 2000) and Gray's Anatomy, 37th edn (Williams et al., 1989 croarray can be balanced against another, or intensities can be normalized relative to a set of control array elements. Thus, the schema needs to capture a variety of data processing methods. Furthermore, different people using different parameters may run the same methods or an update of the processing may be desired given new information on the quality of certain array elements. We separate the application (and user) independent data in SpotResult and SpotFamilyResult from application (and user) dependent data by placing the latter into separate tables, SpotResultAnalysis and SpotFamilyResultAnalysis, respectively. In this manner, we leave the original data intact and at the same time we provide the basic preprocessed data for various subsequent analyses while keeping track of the individual stages of data manipulation (e.g. data cleansing followed by normalization of intensities). Detailed information on the analysis method used and its associated parameters for a particular instance or 'run' of the method are tracked through the meta-data set of tables. These act as an electronic laboratory notebook, allowing the efficient retrieval of results from a particular analysis, as well as the use of these results as values for subsequent analyses. Actual query times will vary depending on network and server load. All the public data and associated annotation stored in RAD for these experiments can be accessed at http://www.cbil.upenn.edu/RAD2. These experiments currently consist of studies done using human samples with an emphasis on hematopoiesis reflecting our research interests (Alizadeh et al., 2000; Iyer et al., 1999; SageMap; Tamayo et al., 1999) . We will be seeking coverage of hematopoiesis and more broadly, stem cells of various types in the inclusion of new experiments. Current population of the database is through the use of Perl scripts however web-based forms are being designed to facilitate entry of experiment annotation (e.g. sample descriptions, experimental conditions). XML has been discussed as a data exchange format for array-based gene expression data (MGED group) and an XML parser could easily be built to load data directly into (and retrieve data out of) RAD.
IMPLEMENTATION
The RAD web interface allows experimental data to be viewed and compared by two different approaches. One approach allows the user to select an experiment and retrieve all associated information including what other experiments belong in the same group. Raw or processed data from all experiments in the same group can be obtained in a single table. For microarray experiments, the related experiment is also provided. Links are provided that return all associated SpotResult details for each data value allowing the user to inspect all the parameter values for an array element generated by the image analysis program. Links are also provided to the allgenes (GUS) index and to GenBank where available.
The second approach to accessing experimental data allows the user to take advantage of the strengths of RAD, namely, ontologies, evidence, and interface to a gene index. A query of the form 'What genes are expressed in the top 20% of normal B-lymphocytes and mapped to chromosome 19?' can be built. First, the ontologies for anatomy (B-lymphocyte) and disease (normal) are used to pick experiments. Next, the SpotFamilyResultAnalysis table is used to identify high expressing genes after elimination of controls and appropriate preprocessing. It is possible that the set of experiments chosen are from studies using different platforms. The gene index is used through the RAD GUSdev rel table to provide a common description for genes shared by all the experiments selected. The gene index is also used to filter the genes returned based on the annotation on the gene index itself. In this case, the annotation used from GUS is radiation hybrid mapping of ESTs to identify genes located on each chromosome. Other queries are planned which utilize some of the other types of annotation in GUS such as cellular role.
The current RAD schema was built using Power Designer DataArchitect and implemented in both Sybase 11.9.2 and Oracle 8i. The schema is compliant with the minimum annotations recommended at the Second International Meeting on Microarray Data Standards, Annotations, Ontologies, and Databases (http://www.mged.org). A relational system was chosen in order to maintain a common database management system with other database projects in our group. Data was loaded using Perl scripts based on a Perl object layer. The web interface uses Java servlets and Perl CGI scripts to query the database. Microarray data was obtained from http: //genome-www.stanford.edu/serum/ (Iyer et al., 1999) and from http://llmpp.nih.gov/lymphoma/data.shtml (Alizadeh et al., 2000) . Affymetrix data was obtained from http://www-genome.wi.mit.edu/MPR/ (Tamayo et al., 1999) . SAGE data and the mapping of sequence tags to UniGene clusters were obtained from http://www.ncbi.nlm.nih.gov/SAGE.
DISCUSSION
The main goal of the RAD schema was to capture gene expression data from different types of highly parallel technologies. These technologies were primarily arraybased but we strove to include EST-based technologies (such as SAGE) as well. As a result, many of the table and attribute names describe array features (e.g. spot, hybridization conditions, etc.). These features can be readily adapted to the specific technology. For example, the default value in SpotFamilyResult is used to hold the averaged signal intensities for gene tags represented on an array as well as the counts for a sequence tag in a SAGE experiment. The sample tables hold the same information for all technologies.
Other gene expression schemas have been made available by investigators at their web sites. A comprehensive table listing various database efforts and their features has been put together (http: //www.ncgr.org/research/genex/other tools.html). Databases designed to hold array-based gene expression data for which documentation and/or schemas are available include GeneX (NCGR), AMAD (UCSF), ArrayDB (NHGRI), ExpressDB (Harvard), ArrayExpress (EBI), Gene Expression Omnibus or GEO (NCBI), GeneChip (Affymetrix), GeneSpring (Silicon Genetics), and MicroArray DB (Stanford). RAD is also included in this table. Of these, only ExpressDB (Aach et al., 2000) , GEO (Wheeler et al., 2000) , and RAD are designed to hold SAGE data. RAD is the only database that incorporates ontologies for taxonomy, anatomy, and disease. GEO also appears to incorporate taxonomy and uses MESH terms as a source of controlled vocabulary. Also missing from most of these databases is the use of a gene index. Links to external databases are generally included but these result in the treatment of each array element as independent. Although RAD uses the allgenes index there are certainly alternatives. ArrayDB (Ermolaeva et al., 1998) uses a gene index in the form of UniGene clusters while ExpressDB uses SGD for yeast. ExpressDB is also incorporating MIPS (Mewes et al., 2000) to provide cellular role annotation, while GeneSpring allows the user to provide annotated lists of genes. Finally, only RAD incorporates the ability to store multiple types of processed data (i.e. cleansed and normalized) and details of the processing. To compare data from different studies by different tools is likely to require more flexibility than using a single type of normalization such as the ERA (estimated relative abundance) described by Aach et al. (2000) (and not stored in ExpressDB). Indeed, a result from that paper was that the ERA approach did not work well for microarray data. Through the use of the ExperimentGroups table, collections of experiments across which comparisons are meaningful can be formed. Finally, the structure of the RAD schema was conceived from the standpoint of a physical experiment, and as such grew to accommodate many different types of gene expression technologies. We foresee this flexibility to continue as new technologies, such as MPSS (Brenner et al., 2000) , emerge. The general model can also be applied to develop a resource for proteomic data as well.
In summary, the RAD schema captures gene expression data from varying technologies allowing for the possibility of cross-platform and cross-experiment comparisons. These comparisons are made possible in part because both raw and processed data are captured with tracking of how the data is processed and alternative values allowed. Integration of information about the genes analyzed is provided by a separate gene index. A precise and richly detailed description of the sample investigated is provided through the use of ontologies. With this schema established, future database efforts will focus on increasing content and expanding functionality of the web interface.
